For citations:
Trukhan DI, Degovtsov EN, Mazurov AL. Choice of protonic pump inhibitor with regard to multimorbidity: a focus on rabeprazol. Meditsinskiy sovet = Medical Council. 2019;(3):34-42. (In Russ.) https://doi.org/10.21518/2079-701X-2019-3-34-42